Malignant neoplasm of cerebellum
ICD-10 C71.6 is a billable code used to indicate a diagnosis of malignant neoplasm of cerebellum.
C71.6 refers to a malignant neoplasm located in the cerebellum, which is a part of the central nervous system (CNS) responsible for coordination, balance, and motor control. Malignant tumors in this region can arise from various cell types, including astrocytes, oligodendrocytes, and ependymal cells, or may metastasize from other primary cancers. Symptoms often include headaches, nausea, vomiting, ataxia, and changes in coordination or balance. Imaging studies, particularly MRI, are crucial for diagnosis, revealing the tumor's size, location, and potential involvement of surrounding structures. Molecular markers, such as IDH mutations and 1p/19q co-deletion status, can provide insights into tumor behavior and guide treatment options. Treatment typically involves a multidisciplinary approach, including surgery, radiation therapy, and chemotherapy, depending on the tumor type and stage. Accurate coding is essential for appropriate reimbursement and tracking of treatment outcomes.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis and treatment planning for cerebellar tumors, follow-up care.
Ensure accurate coding of tumor type and treatment modalities.
Neurological assessments, imaging results, and symptom documentation.
Evaluation of neurological deficits, coordination issues, and management of symptoms.
Document neurological function changes and their impact on daily activities.
Used during surgical intervention for C71.6.
Operative report detailing the procedure and findings.
Neurosurgery documentation must include tumor type and extent of resection.
MRI is typically required to confirm the presence and extent of the cerebellar tumor, along with any relevant imaging studies that document changes over time.
